drugset / Trial / NCT00472771
INNO-206 in Patients With Small Cell Lung Cancer (SCLC)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether INNO-206 is effective in the treatment of small cell lung cancer.
Timeline
- Start
- 2008-05
- Primary completion
- —
- Completion
- 2008-11
Outcome
Outcome not reported
Stopped: “Terminated due to clinical trial material production delays”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aldoxorubicin | Small molecule | — | — |